Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1500648800HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Group again petitions FDA to ban Novo Nordisk's Victoza

06.06.2014 / Fierce Pharma

While Victoza brought in more than $2 billion last year, it has been dogged by concerns that it raises the risk of pancreatitis–and despite it and other similar drugs being cleared by reviews by both the FDA and EU regulators this year, some keep pushing the FDA to consider pulling it off the market.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: